Aurora Cannabis Inc (ACB)

[KOLLEGAH]

Aurora cannabis stock


Berenberg Bank ranked Aurora Cannabis in third place in the ranking ranking of listed Canadian marijuana companies. The company is headquartered in Edmonton, Alberta, and is a cannabis producer with sales and operations in 20 countries across five continents. In terms of scalability, the analysts point to a market capitalization of the equivalent of around 5.27 billion euros, which is accompanied by net debt as at 30 June of 75.6 million euros. The current capacity is estimated at 39.3 tonnes and the already funded capacity at 570 tonnes.



In addition to the home market, the presence includes the following countries: Denmark, Spain, Lithuania, Germany, Italy, Malta, Israel, Australia, South Africa, Brazil, Colombia, Mexico, Cayman Islands and Uruguay. The group has publicly announced delivery contracts in Canada over 63 tons. These agreements affect 89.1 percent of the entire Canadian population. In the leisure retail sector, the Group has two retailers: Alcanna (formerly Liquor Stores

NA), a retailer of alcoholic beverages with 229 stores in Alberta. Aurora holds a 25 percent stake in the company. Alcanna has exclusive rights to open cannabis shops under the Aurora brand under the license agreement. The Group is planning to open 37 stores in Alberta (the maximum allowed by provincial regulations in the first year of legalization). It will convert several existing liquor stores into cannabis retail stores.

Added to this is the West-based retailer Choom. The Group submitted 45 applications for markets here. Aurora initially acquired an 8% interest in the company and on November 5, 2018, invested another 20 million Canadian dollars, securing the right to acquire a 40% interest. Aurora also has strong market access for its medical devices and signed agreements with Canadian pharmacies Shoppers Drug Mart (1,200 stores) and Pharmasave (650 stores).

In Germany, Aurora Pedanios, Germany's largest provider of medical cannabis, has acquired more than 2,000 pharmacies. Pedanios is one of the few EU GMP certification companies required to import and distribute cannabis. The company offers a wide range of recreational products, including cannabis plants, concentrates, pre-rolls, oils and hemp-based foods. Through the partnership with Namaste, the group also offers vaping products. In addition, they hold a stake of 17.62 percent in The Green Organic Dutchman

(TGOD), a producer of high-quality organic cannabis. The agreement allows Aurora to purchase up to 20 percent of TGOD's annual output. The group also offers a variety of medicinal cannabis products, including dried plants, oils, capsules, transdermal patches, topics and creams. It is also GMP certified, an important requirement for brands that deliver cannabis to the medical market. The group owns the four medical brands Aurora, CanniMed, MedReleaf and Anandia Labs. Aurora also owns a range of recreational cannabis brands, including San Rafael , Asse, AltaVie and MüV, which manufacture products such as inhalers, transdermal patches, sports gels, lotions and creams.



For Aurora Cannabis, the analysts' consensus currently estimates that earnings per share may increase from 0.15 to 0.29 Canadian dollars by 2017/18 through 2020/21 (30.06.). On the latter basis, the current $ 8.25 note reveals an estimated P / E of 28.5.
from the Source: Its going up just kick back relax.....

https://www.boerse-online.de/nachrichten/aktien/cannabis-aktien-fuenf-aussichtsreiche-marihuana-unternehmen-1027748464/4Technicals


Aurora Cannabis' share price has risen from $ 0.20 to $ 11.94 from August 2015 to January 2018 in US trading. After this strong performance, however, consolidation tendencies have also become widespread in this case. These are reflected in the chart in a sideways trend that prevails this year, which is still completely intact.



Profile


With a current funded capacity of 430,000 kilograms per year, which will increase to more than 570,000 kilograms per year following the successful completion of the MedReleaf acquisition, Aurora identifies itself as one of the world's largest and fastest growing cannabis companies. Through subsidiaries and strategic partnerships, the company has achieved a differentiation in terms of geographic reach, production, technology, product offering and execution.

With a growing number of countries implementing medical cannabis laws, the company has embarked on an aggressive international expansion strategy, with activities and / or sales and investments in Germany, Denmark, Italy and Australia currently underway. The company operates from cultivation to production to customer service at all levels. Among other things, the launch of the world's only mobile app for the order of medically prescribed cannabis was an innovation.